Download our cell line development technical presentation

Abzena’s focus on both productivity and quality allows our Composite CHO™ technology to be utilised for the development of mAbs, mAb fragments, fusion proteins, novel biomolecules and biosimilars. Yield and product quality are key to development and Composite CHO™ achieves the high expression levels of the desired antibodies and proteins (figure in the flyer). We ensure all materials we use to develop the cell line are free of animal-derived products and the cells are grown in a chemically defined medium.

Interested in our services? Get In Touch